TuHURA Biosciences Draws Additional $1.9M from Credit Facility
HURA has more than doubled off its 52-week low of $0.41 on light trading volume (0.3× avg).
Summary
TuHURA Biosciences drew an additional $1.9 million from its $50 million revolving credit facility, providing further liquidity for general corporate purposes.
Key Events · Financing and Capital Events · HURA
-
Additional Credit Facility Draw
TuHURA Biosciences drew an additional $1.9 million from its $50 million revolving credit facility on June 30, 2026.
-
Liquidity for Operations
The funds are expected to be used for general corporate purposes, continuing to support the company's operations and extend its cash runway.
-
Follows Prior Draws
This draw follows previous utilization of the facility, which was established on April 21, 2026, and is a key component of the company's strategy to mitigate prior going concern concerns.
Analysis · HURA · Life Sciences
This 8-K reports TuHURA Biosciences drawing an additional $1.9 million from its existing $50 million revolving credit facility. This action provides crucial liquidity for general corporate purposes, continuing to extend the company's cash runway as previously disclosed. The company has been actively utilizing this facility to address prior going concern warnings and fund ongoing operations.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 37.5% of the 3362 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HURA was trading at $2.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $142.6M. The 52-week trading range was $0.41 to $3.90. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.